Probiotics for the treatment of inflammatory bowel disease
- PMID: 22581276
- DOI: 10.1007/s11894-012-0265-5
Probiotics for the treatment of inflammatory bowel disease
Abstract
Probiotics are organisms which provide a desired and beneficial effect on human health. With recent evidence implicating a disruption in the balance of the gastrointestinal microbiome and intestinal immunity as a potential trigger for inflammatory bowel disease (IBD), there has been growing interest in using probiotics as an adjunct to standard anti-inflammatory and immune suppressing therapy. Animal models describe potential and plausible mechanisms of action for probiotics to counter inflammation of colonic mucosa. Although there are insufficient data to recommend probiotics in ulcerative colitis or Crohn's disease, good evidence supports the use of specific probiotics for maintenance of remission in pouchitis. Although there are limited regulatory standards for the agents, probiotics are relatively safe with minimal reported side effects or contraindications. More rigorous studies need to be published supporting efficacy and safety of these agents before they become a mainstay of IBD medical treatment.
Similar articles
-
Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?Curr Clin Pharmacol. 2020;15(3):216-233. doi: 10.2174/1574884715666200312100237. Curr Clin Pharmacol. 2020. PMID: 32164516 Review.
-
Clinical usefulness of probiotics in inflammatory bowel diseases.J Physiol Pharmacol. 2006 Nov;57 Suppl 9:23-33. J Physiol Pharmacol. 2006. PMID: 17242485 Review.
-
Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.Proc Nutr Soc. 2007 Aug;66(3):307-15. doi: 10.1017/S0029665107005563. Proc Nutr Soc. 2007. PMID: 17637082 Review.
-
Probiotics in the treatment of human inflammatory bowel diseases: update 2011.J Clin Gastroenterol. 2011 Nov;45 Suppl:S139-44. doi: 10.1097/MCG.0b013e31822103f7. J Clin Gastroenterol. 2011. PMID: 21992953 Review.
-
Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?Mol Nutr Food Res. 2008 Aug;52(8):906-12. doi: 10.1002/mnfr.200700147. Mol Nutr Food Res. 2008. PMID: 18384087 Review.
Cited by
-
Enteropathic spondyloarthritis: from diagnosis to treatment.Clin Dev Immunol. 2013;2013:631408. doi: 10.1155/2013/631408. Epub 2013 Apr 15. Clin Dev Immunol. 2013. PMID: 23690825 Free PMC article. Review.
-
Infectious etiopathogenesis of Crohn's disease.World J Gastroenterol. 2014 Sep 14;20(34):12102-17. doi: 10.3748/wjg.v20.i34.12102. World J Gastroenterol. 2014. PMID: 25232246 Free PMC article. Review.
-
The Dietary Intervention of Transgenic Low-Gliadin Wheat Bread in Patients with Non-Celiac Gluten Sensitivity (NCGS) Showed No Differences with Gluten Free Diet (GFD) but Provides Better Gut Microbiota Profile.Nutrients. 2018 Dec 12;10(12):1964. doi: 10.3390/nu10121964. Nutrients. 2018. PMID: 30545051 Free PMC article.
-
Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease.World J Gastroenterol. 2014 Sep 7;20(33):11505-24. doi: 10.3748/wjg.v20.i33.11505. World J Gastroenterol. 2014. PMID: 25206258 Free PMC article. Review.
-
Gut microbiota, inflammation and colorectal cancer.Genes Dis. 2016 Jun;3(2):130-143. doi: 10.1016/j.gendis.2016.03.004. Epub 2016 Apr 13. Genes Dis. 2016. PMID: 28078319 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources